QAS.AI Launches Clinical-Ready Demo, Deploys at Gates Vascular Institute
QAS.AI Launches Clinical-Ready Demo, Deploys at Gates Vascular Institute
Oct 15, 2023



We’re thrilled to announce the launch of our interactive software demo, developed in collaboration with Morehead Design, showcasing QAS.AI’s real-time AI guidance for neuroendovascular procedures.
This milestone marks the transition from prototype to clinical deployment—with our system now live and actively undergoing testing at Gates Vascular Institute, a nationally recognized center for cerebrovascular innovation.
The demo highlights QAS.AI’s ability to:
Automatically detect aneurysms and injection inlets
Analyze contrast dynamics from angiographic sequences
Provide probability-based predictions for aneurysm occlusion at 6 months
Deliver results in under 1 second, directly in the angio suite
This clinical integration represents a key step toward translating our NSF- and UB CAT-supported research into a standard-of-care decision support tool.
We’re thrilled to announce the launch of our interactive software demo, developed in collaboration with Morehead Design, showcasing QAS.AI’s real-time AI guidance for neuroendovascular procedures.
This milestone marks the transition from prototype to clinical deployment—with our system now live and actively undergoing testing at Gates Vascular Institute, a nationally recognized center for cerebrovascular innovation.
The demo highlights QAS.AI’s ability to:
Automatically detect aneurysms and injection inlets
Analyze contrast dynamics from angiographic sequences
Provide probability-based predictions for aneurysm occlusion at 6 months
Deliver results in under 1 second, directly in the angio suite
This clinical integration represents a key step toward translating our NSF- and UB CAT-supported research into a standard-of-care decision support tool.